CIK 2057060
GF FUND MANAGEMENT CO. LTD.
Institutional 13F holdings & portfolio
Holdings
643
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
4
Holdings
13F filings as of Dec 31, 2025 · Showing 451–500 of 643
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| ALVO | Alvotech SA | 6K | $15K–$50K | SH |
| TRVI | Trevi Therapeutics Inc | 3K | $15K–$50K | SH |
| FTRE | Fortrea Holdings Inc | 2K | $15K–$50K | SH |
| AGIO | Agios Pharmaceuticals Inc | 1K | $15K–$50K | SH |
| DRH | DiamondRock Hospitality Co | 3K | $15K–$50K | SH |
| DEI | Douglas Emmett Inc | 3K | $15K–$50K | SH |
| IMCR | Immunocore Holdings PLC | 857 | $15K–$50K | SH |
| EYPT | EyePoint Inc | 2K | $15K–$50K | SH |
| TSHA | Taysha Gene Therapies Inc | 5K | $15K–$50K | SH |
| INVA | Innoviva Inc | 1K | $15K–$50K | SH |
| QURE | uniQure NV | 1K | $15K–$50K | SH |
| — | AtaiBeckley Inc | 7K | $15K–$50K | SH |
| KOD | Kodiak Sciences Inc | 1K | $15K–$50K | SH |
| PGEN | Precigen Inc | 7K | $15K–$50K | SH |
| RLAY | Relay Therapeutics Inc | 3K | $15K–$50K | SH |
| UPB | Upstream Bio Inc | 1K | $15K–$50K | SH |
| ORKA | Oruka Therapeutics Inc | 950 | $15K–$50K | SH |
| COLL | Collegium Pharmaceutical Inc | 620 | $15K–$50K | SH |
| NVCR | Novocure Ltd | 2K | $15K–$50K | SH |
| RAPP | Rapport Therapeutics Inc | 935 | $15K–$50K | SH |
| GNL | Global Net Lease Inc | 3K | $15K–$50K | SH |
| ARDX | Ardelyx Inc | 5K | $15K–$50K | SH |
| MBX | MBX Biosciences Inc | 882 | $15K–$50K | SH |
| TYRA | Tyra Biosciences Inc | 1K | $15K–$50K | SH |
| SHO | Sunstone Hotel Investors Inc | 3K | $15K–$50K | SH |
| ANAB | AnaptysBio Inc | 543 | $15K–$50K | SH |
| LTC | LTC Properties Inc | 763 | $15K–$50K | SH |
| AMLX | Amylyx Pharmaceuticals Inc | 2K | $15K–$50K | SH |
| DFTX | Mind Medicine MindMed Inc | 2K | $15K–$50K | SH |
| XERS | Xeris Biopharma Holdings Inc | 3K | $15K–$50K | SH |
| ELME | Elme Communities | 1K | $15K–$50K | SH |
| ALEX | Alexander & Baldwin Inc | 1K | $15K–$50K | SH |
| SEPN | Septerna Inc | 878 | $15K–$50K | SH |
| NTST | NETSTREIT Corp | 1K | $15K–$50K | SH |
| GTY | Getty Realty Corp | 891 | $15K–$50K | SH |
| AMPH | Amphastar Pharmaceuticals Inc | 902 | $15K–$50K | SH |
| SVRA | Savara Inc | 4K | $15K–$50K | SH |
| OMER | Omeros Corp | 1K | $15K–$50K | SH |
| TNGX | Tango Therapeutics Inc | 3K | $15K–$50K | SH |
| PHAT | Phathom Pharmaceuticals Inc | 1K | $15K–$50K | SH |
| SPRY | ARS Pharmaceuticals Inc | 2K | $15K–$50K | SH |
| INBX | Inhibrx Biosciences Inc | 285 | $15K–$50K | SH |
| XHR | Xenia Hotels & Resorts Inc | 2K | $15K–$50K | SH |
| GRFS | Grifols SA | 2K | $15K–$50K | SH |
| PEB | Pebblebrook Hotel Trust | 2K | $15K–$50K | SH |
| CSTL | Castle Biosciences Inc | 573 | $15K–$50K | SH |
| IIPR | Innovative Industrial Properti | 464 | $15K–$50K | SH |
| PCRX | Pacira BioSciences Inc | 844 | $15K–$50K | SH |
| URGN | UroGen Pharma Ltd | 919 | $15K–$50K | SH |
| XNCR | Xencor Inc | 1K | $15K–$50K | SH |